Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 3 months ago Source:  Radcliffe CVRM
A pragmatic, scalable approach to obesity implemented in primary care has the potential to curtail population weight gain, according to findings from the PATHWEIGH trial. The study found that a multi-component care process successfully mitigated the weight gain observed with usual care and increased the likelihood of patients receiving weight-related treatment.¹The PATHWEIGH intervention… View more
Start date: Jul 12, 2025 End date: Jul 15, 2025
ENDO 2025 will take place on July 12th to 15th 2025 in San Francisco at the Moscone Convention Center. ENDO 2025 will host over 7,000 attendees with nearly 2,500 abstracts, and the sessions are set to cover obesity, diabetes, endocrine-disrupting chemicals, growth hormones, thyroid conditions, reproductive health, endocrine cancers, and much more. View more
Research Area(s) / Expertise: Job title: Head of the School of Psychology
Prof Jason Halford is Head of the School of Psychology at the University of Leeds, and President of the European Association for the Study of Obesity (EASO). His research has focused on eating behaviour and weight management, and the role of psychological factors in weight gain and weight loss, with a recent focus on stress and coping. View more
Dr Sabine Steiner is a professor for applied vascular research at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig. Her research areas include epidemiology, restenosis, endovascular interventions, clinical trials, and swine models of vascular disease. View more
Added: 3 months ago Source:  Radcliffe CVRM
Following the primary analysis of the SELECT trial, which demonstrated that semaglutide reduces major adverse cardiovascular events, a new exploratory analysis suggests the treatment also significantly lowers the rate and duration of hospitalisations in patients with established cardiovascular disease (CVD) and overweight or obesity, but without diabetes.¹MethodologyThis prespecified exploratory… View more
Added: 2 months ago Source:  Radcliffe CVRM
With the rising prevalence of obesity and associated cardiovascular-kidney-metabolic (CKM) syndrome, indications for novel therapies are expanding. A new study has quantified the proportion of US adults who meet the approved indications for three key classes of CKM medications, revealing a substantial number are eligible for treatment.¹MethodologyThis cross-sectional study analysed data from… View more
Author(s): Sven M Francque Added: 1 year ago
ECO 2024 — Prof Sven Francque (University of Antwerp, BE) joins us to talk about the new EASL-EASD-EASO Practice Guidelines for MAFLD.In this interview, Prof Francque highlights some of the unmet needs in people with MAFLD (formerly known as NAFLD). He then summarises the key highlights of the latest guidelines, including guidance on treatment options. He also discusses some of the challenges… View more
Research Area(s) / Expertise: Job title: PhD, RD, FHFSA, FASPEN
Dr Salvatore Carbone, PhD, RDN, MS, FHFSA, FASPEN is an Associate Professor and Program Director of the Nutrition Program at the EVMS School of Health Professions, and an Associate Professor within the EVMS Division of Endocrine and Metabolic Disorders, Strelitz Diabetes Center, Department of Internal Medicine, at the Macon & Joan Brock Virginia Health Sciences at Old Dominion University… View more